Longo DL - Search Results

1

Gradual loss of T-helper 1 populations in spleen of mice during progressive tumor growth.

Ghosh P, Komschlies KL, Cippitelli M, Longo DL, Subleski J, Ye J, Sica A, Young HA, Wiltrout RH, Ochoa AC. Ghosh P, et al. Among authors: longo dl. J Natl Cancer Inst. 1995 Oct 4;87(19):1478-83. doi: 10.1093/jnci/87.19.1478. J Natl Cancer Inst. 1995. PMID: 7674335

2

Partial degradation of T-cell signal transduction molecules by contaminating granulocytes during protein extraction of splenic T cells from tumor-bearing mice.

Franco JL, Ghosh P, Wiltrout RH, Carter CR, Zea AH, Momozaki N, Ochoa AC, Longo DL, Sayers TJ, Komschlies KL. Franco JL, et al. Among authors: longo dl. Cancer Res. 1995 Sep 1;55(17):3840-6. Cancer Res. 1995. PMID: 7641202

3

Enhancement by recombinant human interferon alfa of the reversal of multidrug resistance by MRK-16 monoclonal antibody.

Fogler WE, Pearson JW, Volker K, Ariyoshi K, Watabe H, Riggs CW, Wiltrout RH, Longo DL. Fogler WE, et al. Among authors: longo dl. J Natl Cancer Inst. 1995 Jan 18;87(2):94-104. doi: 10.1093/jnci/87.2.94. J Natl Cancer Inst. 1995. PMID: 7707396

4

Cellular and molecular studies in the treatment of murine renal cancer.

Wiltrout RH, Gregorio TA, Fenton RG, Longo DL, Ghosh P, Murphy WJ, Komschlies KL. Wiltrout RH, et al. Among authors: longo dl. Semin Oncol. 1995 Feb;22(1):9-16. Semin Oncol. 1995. PMID: 7855624 Review.

5

Alterations in NF kappa B/Rel family proteins in splenic T-cells from tumor-bearing mice and reversal following therapy.

Ghosh P, Sica A, Young HA, Ye J, Franco JL, Wiltrout RH, Longo DL, Rice NR, Komschlies KL. Ghosh P, et al. Among authors: longo dl. Cancer Res. 1994 Jun 1;54(11):2969-72. Cancer Res. 1994. PMID: 8187083

6

Chemoimmunotoxin therapy against a human colon tumor (HT-29) xenografted into nude mice.

Pearson JW, FitzGerald DJ, Willingham MC, Wiltrout RH, Pastan I, Longo DL. Pearson JW, et al. Among authors: longo dl. Cancer Res. 1989 Jul 1;49(13):3562-7. Cancer Res. 1989. PMID: 2499420

7

Enhanced therapeutic efficacy of an immunotoxin in combination with chemotherapy against an intraperitoneal human tumor xenograft in athymic mice.

Pearson JW, Sivam G, Manger R, Wiltrout RH, Morgan AC Jr, Longo DL. Pearson JW, et al. Among authors: longo dl. Cancer Res. 1989 Sep 15;49(18):4990-5. Cancer Res. 1989. PMID: 2504482

8

Alteration of signal transduction in T cells from cancer patients.

Ochoa AC, Longo DL. Ochoa AC, et al. Among authors: longo dl. Important Adv Oncol. 1995:43-54. Important Adv Oncol. 1995. PMID: 7672813 Review.

9

A phase I clinical trial of flavone-8-acetic acid in combination with interleukin 2.

Holmund JT, Kopp WC, Wiltrout RH, Longo DL, Urba WJ, Janik JE, Sznol M, Conlon KC, Fenton RG, Hornung R, et al. Holmund JT, et al. Among authors: longo dl. J Natl Cancer Inst. 1995 Jan 18;87(2):134-6. doi: 10.1093/jnci/87.2.134. J Natl Cancer Inst. 1995. PMID: 7707385 Clinical Trial. No abstract available.

10

Loss of T-cell receptor zeta chain and p56lck in T-cells infiltrating human renal cell carcinoma.

Finke JH, Zea AH, Stanley J, Longo DL, Mizoguchi H, Tubbs RR, Wiltrout RH, O'Shea JJ, Kudoh S, Klein E, et al. Finke JH, et al. Among authors: longo dl. Cancer Res. 1993 Dec 1;53(23):5613-6. Cancer Res. 1993. PMID: 8242613

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

787 results

Search Page